Ilias Kalafatakis

Dr. Ilias Kalafatakis

University of Crete, Medical School
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
IKIlias Kalafatakis
Ilias Kalafatakis
 Domna  Karagogeos Domna Karagogeos
Domna Karagogeos
Oligodendrocytes, the myelin-making cells of the CNS, regulate the complex process of myelination under physiological and pathological conditions, significantly aided by other glial cell types such as microglia, the brain-resident, macrophage-like innate immune cells. In this review, we summarize how oligodendrocytes orchestrate myelination, and especially myelin repair after damage, and present novel aspects of oligodendroglial functions. We emphasize the contribution of microglia in the generation and regeneration of myelin by discussing their beneficial and detrimental roles, especially in remyelination, underlining the cellular and molecular components involved. Finally, we present recent findings towards human stem cell-derived preclinical models for the study of microglia in human pathologies and on the role of microbiome on glial cell functions.

1 November 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
IKIoanna Koumentakou
Ioanna Koumentakou
Zoi TerzopoulouZoi Terzopoulou
Zoi Terzopoulou
AMAnna Michopoulou
Anna Michopoulou
IKIlias Kalafatakis
Ilias Kalafatakis
KTKonstantinos Theodorakis
Konstantinos Theodorakis
Dimitrios BikiarisDimitrios Bikiaris
Dimitrios Bikiaris

22 November 2017 in Glia
Verified
Journal Article
Closed access
PDF file
LZLida Zoupi
Lida Zoupi
MSMaria Savvaki
Maria Savvaki
KKKaterina Kalemaki
Katerina Kalemaki
IKIlias Kalafatakis
Ilias Kalafatakis
KSKyriaki Sidiropoulou
Kyriaki Sidiropoulou
 Domna  Karagogeos Domna Karagogeos
Domna Karagogeos

Verified
Journal Article
Open access
PDF file
IKIlias Kalafatakis
Ilias Kalafatakis
FPFevronia Papagianni
Fevronia Papagianni
KTKostas Theodorakis
Kostas Theodorakis
 Domna  Karagogeos Domna Karagogeos
Domna Karagogeos
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) that causes progressive neurological disability in most patients due to neurodegeneration. Activated immune cells infiltrate the CNS, triggering an inflammatory cascade that leads to demyelination and axonal injury. Non-inflammatory mechanisms are also involved in axonal degeneration, although they are not fully elucidated yet. Current therapies focus on immunosuppression; however, no therapies to promote regeneration, myelin repair, or maintenance are currently available. Two different negative regulators of myelination have been proposed as promising targets to induce remyelination and regeneration, namely the Nogo-A and LINGO-1 proteins. Although Nogo-A was first discovered as a potent neurite outgrowth inhibitor in the CNS, it has emerged as a multifunctional protein. It is involved in numerous developmental processes and is necessary for shaping and later maintaining CNS structure and functionality. However, the growth-restricting properties of Nogo-A have negative effects on CNS injury or disease. LINGO-1 is also an inhibitor of neurite outgrowth, axonal regeneration, oligodendrocyte differentiation, and myelin production. Inhibiting the actions of Nogo-A or LINGO-1 promotes remyelination both in vitro and in vivo, while Nogo-A or LINGO-1 antagonists have been suggested as promising therapeutic approaches for demyelinating diseases. In this review, we focus on these two negative regulators of myelination while also providing an overview of the available data on the effects of Nogo-A and LINGO-1 inhibition on oligodendrocyte differentiation and remyelination.

13 January 2021 in Life
Verified
Journal Article
Open access
PDF file
IKIlias Kalafatakis
Ilias Kalafatakis
MSMaria Savvaki
Maria Savvaki
TVTheodora Velona
Theodora Velona
 Domna  Karagogeos Domna Karagogeos
Domna Karagogeos
Demyelinating pathologies comprise of a variety of conditions where either central or peripheral myelin is attacked, resulting in white matter lesions and neurodegeneration. Myelinated axons are organized into molecularly distinct domains, and this segregation is crucial for their proper function. These defined domains are differentially affected at the different stages of demyelination as well as at the lesion and perilesion sites. Among the main players in myelinated axon organization are proteins of the contactin (CNTN) group of the immunoglobulin superfamily (IgSF) of cell adhesion molecules, namely Contactin-1 and Contactin-2 (CNTN1, CNTN2). The two contactins perform their functions through intermolecular interactions, which are crucial for myelinated axon integrity and functionality. In this review, we focus on the implication of these two molecules as well as their interactors in demyelinating pathologies in humans. At first, we describe the organization and function of myelinated axons in the central (CNS) and the peripheral (PNS) nervous system, further analyzing the role of CNTN1 and CNTN2 as well as their interactors in myelination. In the last section, studies showing the correlation of the two contactins with demyelinating pathologies are reviewed, highlighting the importance of these recognition molecules in shaping the function of the nervous system in multiple ways.

29 June 2020 in Brain Structure and Function
Verified
Journal Article
Closed access
PDF file
IKIlias Kalafatakis
Ilias Kalafatakis
KKKonstantinos Kalafatakis
Konstantinos Kalafatakis
ATAlexandros Tsimpolis
Alexandros Tsimpolis
NGNikos Giannakeas
Nikos Giannakeas
Markos G. TsipourasMarkos G. Tsipouras
Markos G. Tsipouras
DKDomna Karagogeos
Domna Karagogeos